FDA Purchases XPS license – Developed by RCPE and Distributed by InSilicoTrials – as In-House Simulation Tool

MILAN, April 4, 2024 /PRNewswire/ — The Research Center Pharmaceutical Engineering (RCPE) and InSilicoTrials are pleased to announce a significant milestone in their collaborative journey with the United States Food and Drug Administration (FDA). The FDA has recently purchased an XPS…